Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas purchased 29,158 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $0.86 per share, for a total transaction of $25,075.88. Following the purchase, the chief executive officer now owns 4,164,789 shares in the company, valued at $3,581,718.54. This represents a 0.71 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Grigorios Siokas also recently made the following trade(s):
- On Wednesday, January 15th, Grigorios Siokas acquired 62,500 shares of Cosmos Health stock. The shares were bought at an average cost of $0.80 per share, with a total value of $50,000.00.
- On Monday, January 13th, Grigorios Siokas bought 163,666 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.61 per share, for a total transaction of $99,836.26.
- On Friday, December 20th, Grigorios Siokas purchased 257,334 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.58 per share, with a total value of $149,253.72.
Cosmos Health Price Performance
Shares of Cosmos Health stock opened at $0.77 on Thursday. The stock has a market capitalization of $17.94 million, a price-to-earnings ratio of -0.32 and a beta of 5.57. The firm’s 50-day moving average price is $0.72 and its two-hundred day moving average price is $0.91. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08. Cosmos Health Inc. has a 1-year low of $0.47 and a 1-year high of $1.58.
Cosmos Health Company Profile
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Read More
- Five stocks we like better than Cosmos Health
- Top Stocks Investing in 5G Technology
- Oracle Announces Game-Changing News for the AI Industry
- How to Effectively Use the MarketBeat Ratings Screener
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.